A First-in-Human Study to Evaluate JCXH-105, an srRNA-based Herpes Zoster Vaccine

Conditions:   Herpes Zoster (HZ);   Shingles;   Infectious Disease Interventions:   Biological: JCXH-105;   Biological: Active Control (Shingrix) Sponsors:   Immorna Biotherapeutics, Inc.;   ICON plc Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials